ライフサイエンスコーパス: serum bactericidal activity

1 dy binding, a phenotype that correlates with serum bactericidal activity.

2 ria meningitidis and increases resistance to serum bactericidal activity.

3 resulted in high-titer complement-dependent serum bactericidal activity.

4 specific antibodies were measured as well as serum bactericidal activity.

5 C4bp to OmpA and also significantly enhance serum bactericidal activity.

6 lis 2951 is resistant to complement-mediated serum bactericidal activity.

7 s host-like antigen blocks antibody-mediated serum bactericidal activity.

8 reactive with each other and associated with serum bactericidal activity.

9 cal lipooligosaccharide causes resistance to serum bactericidal activity.

10 resistance to killing by complement-mediated serum bactericidal activity.

11 nosorbent assay (ELISA) and by assessment of serum bactericidal activity.

12 found that immunization with Bexsero elicits serum bactericidal activity against N. cinerea, which is

13 ted with decreased vaginal bioburden; higher serum bactericidal activity against nonsialylated gonoco

14 induced higher serum and vaginal IgA levels, serum bactericidal activity against sialylated gonococci

15 On the basis of serum bactericidal activity and/or passive protection, 4

16 Serum bactericidal activity confers protection against m

17 ercentage of infants with a human complement serum bactericidal activity (hSBA) titer >or=1:4 after a

18 ibodies, capsular group Y IgG antibodies and serum bactericidal activity in concomitant serum samples

19 Despite eliciting serum bactericidal activity in mice, a recombinant NspA

20 red for immunogenicity and ability to induce serum bactericidal activity in mice.

21 Serum bactericidal activity may serve as a correlate of

22 ti-A polysaccharide antibodies and increased serum bactericidal activity measured using rabbit comple

23 f individual LPS structures to resistance to serum bactericidal activity mediated by antibody and C-r

24 In addition, postvaccination increases in serum bactericidal activity of at least 30% were observe

25 Susceptibility to serum bactericidal activity ranged from extremely sensit

26 correlate with the resistance of strains to serum bactericidal activity; rather, the loss of free LN

27 han heptose I were sensitive to CRP-mediated serum bactericidal activity regardless of the genetic ba

28 Serum bactericidal activity required the binding of C-re

29 correlated with an increase in detection of serum bactericidal activity (SBA) against both colonizin

30 ine increasing anti-MenC antibody titers and serum bactericidal activity (SBA) against MenC compared

31 tigen, activate classical complement pathway serum bactericidal activity (SBA) and block binding of t

32 Serum bactericidal activity (SBA) and ELISA antibody lev

33 Antibodies to STm were measured by serum bactericidal activity (SBA) assay, and anti-STm im

34 We identified predictors of elevated NmW-135 serum bactericidal activity (SBA), a functional correlat

35 the terminal complement pathway required for serum bactericidal activity (SBA).

36 ection 2 [day 113; day 197], 100%; 97.0% and serum bactericidal activity [SBA] after injection 1, 94.

37 rthermore, the nonfunctional V3 fHbps elicit serum bactericidal activity that is equivalent to or hig

38 All three vaccines elicited high titers of serum bactericidal activity that roughly correlated with

39 which result in greater complement-mediated serum bactericidal activity; these epitopes may be obscu

40 portion of children immunized as infants had serum bactericidal activity titers > or =1 : 4 (consider

41 The protective effect of karilysin against serum bactericidal activity was attributable to its abil

42 s against infection with 6275 even when high serum bactericidal activity was induced.

43 Serum bactericidal activity was measured with human comp

44 h high levels of specific IgG antibodies and serum bactericidal activity while recent strain acquisit